Use of dinuclear iron complexes having sulfur-containing ligands as carbon monoxide-releasing pharmacological agents e.g. for treating hypertension, cancer, tissue damage by irradiation, post-ischemic injury, atherosclerosis or sepsis

摘要

Use of dinuclear iron complexes (A) having sulfur-containing ligands as carbon monoxide-releasing pharmacological agents, is claimed. ACTIVITY : Hypotensive; Cytostatic; Vasotropic; Antiarteriosclerotic; Antibacterial; Immunosuppressive; Antianginal; Cardiant; Antiinflammatory; Vasodilator; Neuroprotective. MECHANISM OF ACTION : None given.